top of page
Supported projects
METHYS Dx
A diagnostics company developing real-time liquid biopsy tests based on proprietary DNA methylation signatures to monitor cancer evolution and treatment response.
PSCC's entrance
September 2025
Localization
FR - Île-de-France
Modality
DM/DiV
Development status
Medtech - RUO
Award(s)
bottom of page